Clinical Study
Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
Table 2
Comparisons of the biomarkers median values between RCC with tumor size ≤7 versus >7 cm (a) and between Fuhrman grades 1-2 versus 3-4 (b).
(a) |
| | Tumor size | value | | ≤7 cm | >7 cm | | Median | 95% CI | Median | 95% CI |
| CA 15-3 (U/mL) | 19.79 | 18.72–21.20 | 32.84 | 28.90–37.10 | <0.0001 | CA 125 (U/mL) | 10.02 | 9.41–11.31 | 14.75 | 10.62–20.77 | 0.002 | β-2 m (mg/L) | 1.90 | 1.80–2.00 | 2.30 | 2.10–2.70 | <0.0001 |
|
|
(b) |
| | Fuhrman grade | value | | G1-2 | G3-4 | | Median | 95% CI | Median | 95% CI |
| CA 15-3 (U/mL) | 20.06 | 18.99–21.87 | 25.39 | 22.11–27.85 | 0.0007 | CA 125 (U/mL) | 9.67 | 9.16–11.01 | 13.89 | 10.49–16.17 | 0.002 | β-2 m (mg/L) | 2.00 | 1.80–2.00 | 2.31 | 1.99–2.60 | 0.001 |
|
|